SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-283241
Filing Date
2017-09-13
Accepted
2017-09-13 07:31:10
Documents
5
Effectiveness Date
2017-09-13

Document Format Files

Seq Description Document Type Size
1 8-K d421363d8k.htm DEFA14A 46266
2 EX-2.1 d421363dex21.htm EX-2.1 645155
3 EX-10.1 d421363dex101.htm EX-10.1 12892
4 EX-99.1 d421363dex991.htm EX-99.1 24330
5 GRAPHIC g421363g25h24.jpg GRAPHIC 12374
  Complete submission text file 0001193125-17-283241.txt   746844
Mailing Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36829 | Film No.: 171082226
SIC: 2834 Pharmaceutical Preparations